- Bank Leumi reported a net income of 2.61 billion shekels for the second quarter of 2025.
- This marks a 15% increase from the previous year when the net income was 2.27 billion shekels.
- Net interest income rose by 3.7% year-on-year, reaching 4.54 billion shekels.
- The bank has set aside 223 million shekels for loan losses, contrasting with a recovery of 18 million shekels in the same period last year.
- Bank Leumi plans to increase its dividend payout to 50% of the net income for this quarter.
- Analysts have provided three ‘buy’ recommendations, with zero ‘holds’ or ‘sells’.
A look at Bank Leumi Le-Israel BM Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 3 | |
| Growth | 4 | |
| Resilience | 5 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 4.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Bank Leumi Le-Israel BM, a prominent banking institution offering a range of financial services, has garnered favorable Smartkarma Smart Scores. With a strong emphasis on value, growth, resilience, and momentum, the company’s overall outlook appears positive. The high score in resilience indicates a robust capacity to weather challenges, while the solid scores in value and growth highlight promising investment potential. Additionally, the respectable momentum score points towards a positive market sentiment and potential for future growth.
Bank Leumi Le-Israel BM‘s diverse offerings, including consumer loans, mortgages, insurance, and mutual funds, position it as a versatile player in the financial industry. Moreover, its involvement in non-financial corporations within Israel adds another dimension to its operations. With strong Smartkarma Smart Scores across key factors, Bank Leumi Le-Israel BM appears well-positioned for long-term success in the financial market.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
